関: tyrosine transaminase

WordNet

an amino acid found in most proteins; a precursor of several hormones

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2015/08/14 09:08:01」(JST)

wiki en

Tyrosine aminotransferase (or tyrosine transaminase) is an enzyme present in the liver and catalyzes the conversion of tyrosine to 4-hydroxyphenylpyruvate.^[2] In humans, the tyrosine aminotransferase protein is encoded by the TAT gene. A deficiency of the enzyme in humans can result in what is known as Type II Tyrosinemia, wherein there is an abundance of tyrosine as a result of tyrosine failing to undergo an aminotransferase reaction to form 4-hydroxyphenylpyruvate.^[3]

Mechanism

Structures of the three main molecules involved in chemical reaction catalyzed by the tyrosine aminotransferase enzyme are shown below: the amino acid tyrosine, the prosthetic group pyridoxal phosphate, and the resulting product 4-hydroxyphenylpyruvate.

Ribbon diagram of the tyrosine aminotransferase dimer. The prosthetic group PLP is visible in both monomers.^[4]

Each side of the dimer protein includes pyridoxal phosphate (PLP) bonded to the Lys280 residue of the tyrosine aminotransferase molecule. The amine group of tyrosine attacks the alpha carbon of the imine bonded to Lys280, forming a tetrahedral complex and then kicking off the LYS-ENZ. This process is known as transimination by the act of switching out the imine group bonded to PLP. The newly formed PLP-TYR molecule is then attacked by a base.

Ball & stick diagram of the TAT amino acid Lys280 linked to PLP.^[1]

A possible candidate for the base in the mechanism could be Lys280 that was just pushed off of PLP, which sequesters the newly formed amino group of the PLP-TYR molecule. In a similar mechanism of aspartate transaminase, the lysine that forms the initial imine to PLP later acts as the base that attacks the tyrosine in transimination. The electrons left behind from the loss of the proton move down to form a new double bond to the imine, which in turn pushes the already double bonded electrons through PLP and end up as a lone pair on the positively charged nitrogen in the six-membered ring of the molecule. Water attacks the alpha carbon of the imine of PLP-TYR and through acyl substitution kicks off the nitrogen of PLP and forming pyridoxamine phosphate (PMP) and 4-hydroxyphenylpyruvate.

PMP is then regenerated into PLP by transferring its amine group to alpha-ketoglutarate, reforming it's aldehyde functional group. This is followed by another substitution reaction with the Lys280 residue to reform its imine linkage to the enzyme, forming ENZ-PLP.

Active Site

Space filling model depicting non-polar amino acid side chains Phe169 and Ile249. Notice sandwich effect of the two groups to hold PLP in the correct orientation

Tyrosine Aminotransferase as a dimer has two identical active sights. Lys280 is attached to PLP, which is held in place via two nonpolar amino acid side chains; phenylalanine and isoleucine (see thumbnail on right). The PLP is also held in place by hydrogen bonding to surrounding molecules mainly by its phosphate group.

Shown below is one active site at three different magnifications:

Pathology

Tyrosinemia is the most common metabolic disease associated with tyrosine aminotransferase. The disease results from a deficiency in hepatic tyrosine aminotransferase.^[5] Tyrosinemia type II (Richner-Hanhart syndrome, RHS) is a disease of autosomal recessive inheritance characterized by keratitis, palmoplantar hyperkeratosis, mental retardation, and elevated blood tyrosine levels.^[5] Keratitis in Tyrosinemia type II patients is caused by the deposition of tyrosine crystals in the cornea and results in corneal inflammation.^[6] The TAT gene is located on human chromosome 16q22-24 and extends over 10.9 kilobases (kb) containing 12 exons, and its 3.0 kb mRNA codes for a 454-amino acid protein of 50.4 kDa.^[7] Twelve different TAT gene mutations have been reported.^[7]

References

^ ^a ^b PDB: 3DYD ; Karlberg T, Moche M, Andersson J et al. (2008). "Human tyrosine aminotransferase". To be Published.
^ Dietrich JB (April 1992). "Tyrosine aminotransferase: a transaminase among others?". Cellular and molecular biology 38 (2): 95–114. PMID 1349265.
^ Rettenmeier R, Natt E, Zentgraf H, Scherer G (July 1990). "Isolation and characterization of the human tyrosine aminotransferase gene". Nucleic Acids Res. 18 (13): 3853–61. doi:10.1093/nar/18.13.3853. PMC 331086. PMID 1973834.
^ Pettersen, E.F., Goddard, T.D., Huang, C.C., Couch, G.S., Greenblatt, D.M., Meng, E.C., and Ferrin, T.E. (2004). "UCSF Chimera - A Visualization System for Exploratory Research and Analysis.". Comput. Chem. 25 (13): 1605–1612. doi:10.1002/jcc.20084. PMID 15264254.
^ ^a ^b Natt E, Kida K, Odievre M, Di Rocco M, Scherer G (October 1992). "Point mutations in the tyrosine aminotransferase gene in tyrosinemia type II". Proc. Natl. Acad. Sci. U.S.A. 89 (19): 9297–301. doi:10.1073/pnas.89.19.9297. PMC 50113. PMID 1357662.
^ al-Hemidan AI, al-Hazzaa SA (March 1995). "Richner-Hanhart syndrome (tyrosinemia type II). Case report and literature review". Ophthalmic Genet. 16 (1): 21–6. doi:10.3109/13816819509057850. PMID 7648039.
^ ^a ^b Minami-Hori M, Ishida-Yamamoto A, Katoh N, Takahashi H, Iizuka H (January 2006). "Richner-Hanhart syndrome: report of a case with a novel mutation of tyrosine aminotransferase". J. Dermatol. Sci. 41 (1): 82–4. doi:10.1016/j.jdermsci.2005.10.007. PMID 16318910.

Molecular graphics images were produced using the UCSF Chimera package from the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by NIH P41 RR-01081).

External links

Tyrosine aminotransferase at the US National Library of Medicine Medical Subject Headings (MeSH)

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 子癇前症における凝固および血小板機能の異常 abnormalities of coagulation and platelet function in preeclampsia
2. 幼児および小児における播種性血管内凝固 disseminated intravascular coagulation in infants and children
3. HIV感染患者における心血管疾患の病因およびバイオマーカー pathogenesis and biomarkers of cardiovascular disease in hiv infected patients
4. チロシン代謝障害 disorders of tyrosine metabolism
5. 全身疾患と関連した遺伝性ニューロパチー hereditary neuropathies associated with generalized disorders

English Journal

All-trans retinoic acid inhibits proliferation, migration, invasion and induces differentiation of hepa1-6 cells through reversing EMT in vitro.

Cui J1, Gong M2, He Y1, Li Q3, He T2, Bi Y1.
International journal of oncology.Int J Oncol.2015 Nov 6. doi: 10.3892/ijo.2015.3235. [Epub ahead of print]
Hepatocellular carcinoma (HCC) has the characristics of tumor invasiveness, frequent intrahepatic spread and extra hepatic metastases, which affects the therapy efficiency and prognosis. Epithelial-mesenchymal transition (EMT) is now recognized as a key process in tumor invasion, metastasis and the
PMID 26548461

Efficient generation of functional hepatocyte-like cells from menstrual blood-derived stem cells.

Khanjani S1, Khanmohammadi M1, Zarnani AH2,3, Talebi S1, Edalatkhah H1, Eghtesad S4, Nikokar I5, Kazemnejad S1.
Journal of tissue engineering and regenerative medicine.J Tissue Eng Regen Med.2015 Nov;9(11):E124-34. doi: 10.1002/term.1715. Epub 2013 Mar 18.
In recent years, the advantages of menstrual blood-derived stem cells (MenSCs), such as minimal ethical considerations, easy access and high proliferative ability, have inspired scientists to investigate the potential of MenSCs in cell therapy of different diseases. In order to characterize the pote
PMID 23505217

Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study.

Jabbour E1, Kantarjian H2, Ravandi F2, Thomas D2, Huang X3, Faderl S2, Pemmaraju N2, Daver N2, Garcia-Manero G2, Sasaki K2, Cortes J2, Garris R2, Yin CC4, Khoury JD4, Jorgensen J3, Estrov Z2, Bohannan Z2, Konopleva M2, Kadia T2, Jain N2, DiNardo C2, Wierda W2, Jeanis V2, O'Brien S2.
The Lancet. Oncology.Lancet Oncol.2015 Nov;16(15):1547-55. doi: 10.1016/S1470-2045(15)00207-7. Epub 2015 Sep 30.
BACKGROUND: Combination of chemotherapy with a tyrosine-kinase inhibitor is effective in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukaemia. Ponatinib is a more potent BCR-ABL1 inhibitor than all other tyrosine-kinase inhibitors and selectively suppresses the resistant T
PMID 26432046

Japanese Journal

Mechanism of Liver Tyrosine Aminotransferase Increase in Ethanol-Treated Mice and Its Effect on Serum Tyrosine Level

, , [他], , , ,
Journal of nutritional science and vitaminology 53(6), 489-495, 2007-12
… Liver tyrosine aminotransferase (TAT) activity is known to increase with ethanol treatment; … In addition, liver TAT activity was not related to serum tyrosine levels. …
NAID 110006531868

アフラトキシンB_1誘導ラット肝癌由来K2細胞は癌幹細胞の性質を有している

川崎靖,安達尚美,山崎富生,轟理沙,後藤良隆,古宮裕子,倉部誠也,根本清光,出川雅邦,三浦成敏,田代文夫
マイコトキシン 57(2), 87-93, 2007-07-31
今回，我々はアフラトキシンB1 誘発ラット肝癌K2 細胞に幹様細胞（癌幹細胞）が存在することを明らかにするために，side population（SP）細胞およびstemness 遺伝子発現の解析を試みた．ローダミンを用いたフローサイトメーター解析により，K2 細胞は癌幹細胞であるSP 細胞を約89％と高い割合で含んでいることが明らかとなった．さらに，胚性幹細胞の特徴である多分化能と自己複製能の維 …
NAID 10021920179

Richner-Hanhart syndrome : Report of a case with a novel mutation of tyrosine aminotransferase

MINAMI HORI M.,ISHIDA YAMAMOTO A.,TAKAHASHI H.,IIZUKA H.,KATOH N.
Journal of dermatological science 41(1), 82-84, 2006-01-01
NAID 10020550873

「チロシンアミノ基転移酵素」

Tyrosine aminotransferase
Available structures
PDB	Ortholog search: PDBe, RCSB
List of PDB id codes
	3DYD
Identifiers
Symbol	TAT
External IDs	OMIM: 613018 HomoloGene: 37293 GeneCards: TAT Gene
EC number	2.6.1.5
Gene ontology
Molecular function	• L-tyrosine:2-oxoglutarate aminotransferase activity; • amino acid binding; • pyridoxal phosphate binding; • L-phenylalanine:2-oxoglutarate aminotransferase activity;
Cellular component	• cellular_component; • mitochondrion; • cytosol;
Biological process	• 2-oxoglutarate metabolic process; • glutamate metabolic process; • L-phenylalanine catabolic process; • tyrosine catabolic process; • response to oxidative stress; • biosynthetic process; • cellular nitrogen compound metabolic process; • small molecule metabolic process; • response to mercury ion; • response to glucocorticoid;
	Sources: Amigo / QuickGO
Orthologs
	v; t; e;

Search
PMC	articles
PubMed	articles
NCBI	proteins

Tyrosine transaminase
	Human tyrosine aminotransferase (rainbow colored, N-terminus = blue, C-terminus = red) complexed with pyridoxal phosphate (space-filling model).
Identifiers
EC number	2.6.1.5
CAS number	9014-55-5
Databases
IntEnz	IntEnz view
BRENDA	BRENDA entry
ExPASy	NiceZyme view
KEGG	KEGG entry
MetaCyc	metabolic pathway
PRIAM	profile
PDB structures	RCSB PDB PDBe PDBsum
Gene Ontology	AmiGO / EGO
Search
PMC	articles
PubMed	articles
NCBI	proteins

　　[★]

英: tyrosine aminotransferase
関: チロシントランスアミナーゼ、チロシンアミノトランスフェラーゼ

「tyrosine transaminase」

　　[★]

チロシントランスアミナーゼ

関: tyrosine aminotransferase

「チロシンアミノトランスフェラーゼ」

　　[★]

英: tyrosine aminotransferase
関: [[]]

「aminotransferase」

　　[★] アミノトランスフェラーゼ

[Karlberg-1] PDB: 3DYD ; Karlberg T, Moche M, Andersson J et al. (2008). "Human tyrosine aminotransferase". To be Published.

[pmid1349265-2] Dietrich JB (April 1992). "Tyrosine aminotransferase: a transaminase among others?". Cellular and molecular biology 38 (2): 95–114. PMID 1349265.

[pmid1973834-3] Rettenmeier R, Natt E, Zentgraf H, Scherer G (July 1990). "Isolation and characterization of the human tyrosine aminotransferase gene". Nucleic Acids Res. 18 (13): 3853–61. doi:10.1093/nar/18.13.3853. PMC 331086. PMID 1973834.

[Peterson-4] Pettersen, E.F., Goddard, T.D., Huang, C.C., Couch, G.S., Greenblatt, D.M., Meng, E.C., and Ferrin, T.E. (2004). "UCSF Chimera - A Visualization System for Exploratory Research and Analysis.". Comput. Chem. 25 (13): 1605–1612. doi:10.1002/jcc.20084. PMID 15264254.

[pmid1357662-5] Natt E, Kida K, Odievre M, Di Rocco M, Scherer G (October 1992). "Point mutations in the tyrosine aminotransferase gene in tyrosinemia type II". Proc. Natl. Acad. Sci. U.S.A. 89 (19): 9297–301. doi:10.1073/pnas.89.19.9297. PMC 50113. PMID 1357662.

[pmid7648039-6] -Hemidan AI, al-Hazzaa SA (March 1995). "Richner-Hanhart syndrome (tyrosinemia type II). Case report and literature review". Ophthalmic Genet. 16 (1): 21–6. doi:10.3109/13816819509057850. PMID 7648039.

[pmid16318910-7] Minami-Hori M, Ishida-Yamamoto A, Katoh N, Takahashi H, Iizuka H (January 2006). "Richner-Hanhart syndrome: report of a case with a novel mutation of tyrosine aminotransferase". J. Dermatol. Sci. 41 (1): 82–4. doi:10.1016/j.jdermsci.2005.10.007. PMID 16318910.

リンク元	「チロシンアミノ基転移酵素」「tyrosine transaminase」「チロシンアミノトランスフェラーゼ」
関連記事	「aminotransferase」

匿名

検索

案内

案内

tyrosine aminotransferase